Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue
Clinical trial NCT01408953 · TERMINATED
Trial details
- NCT number
- NCT01408953
- Sponsor
- Tirgan, Michael H., M.D.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2012-11-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.